[1
]
Service d'ophtalmologie, Hôpital Pellegrin-CHU de Bordeaux, Bordeaux, France; Université
Bordeaux Segalen, Bordeaux, France; INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique,
Bordeaux, France.
[2
]
Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, Nebraska.
[3
]
Medical University of Vienna, Vienna, Austria.
[4
]
Retina-Vitreous Associates Medical Group, Beverly Hills, California.
[5
]
Department of Ophthalmology, University of Bonn, Bonn, Germany.
[6
]
Ophthalmic Consultants of Boston and Tufts University School of Medicine, Boston,
Massachusetts.
[7
]
Department of Ophthalmology, University of Padova, Padova, Italy.
[8
]
Cole Eye Institute, Cleveland, Ohio.
[9
]
Nagoya University Hospital, Nagoya, Japan.
[10
]
Southeast Retina Center, Augusta, Georgia.
[11
]
Department of Ophthalmology, Duke University, Durham, North Carolina.
[12
]
Vitreous-Retina-Macula Consultants of New York, New York, New York.
[13
]
Regeneron Pharmaceuticals, Inc., Tarrytown, New York.
[14
]
Bayer HealthCare, Berlin, Germany.
[15
]
Bayer HealthCare, Berlin, Germany; University Medical Center Hamburg-Eppendorf, Hamburg,
Germany.
[16
]
Retina Consultants of Houston, Houston, Texas. Electronic address: dmbmd@houstonretina.com.